Why the study?
Does ibopamine alter haemodynamic parameters in patients with left ventricular dysfunction?
Does ibopamine alter haemodynamic parameters in patients with left ventricular dysfunction?
Ibopamine demonstrates a biphasic haemodynamic action in patients with left ventricular dysfunction, characterized by early pressure increases followed by later chronotropic and cardiac output increases.
Answers are grounded in this paper and cite their sources.
May signal early haemodynamic risks with ibopamine in LV dysfunction; leaves open net clinical effects pending controlled trials.
The haemodynamic effects of ibopamine, an oral dopamine derivative, were studied in eight patients with left ventricular dysfunction using invasive catheterisation techniques. 2. An early rise was seen in the mean right atrial pressure (P less than 0.05), the mean capillary wedge pressure (P less than 0.01) and the mean pulmonary arterial pressure (P less than 0.001) which occurred at 15 min and persisted for 30 min. 3. A second, later, positive chronotropic effect was seen as an increase in the heart rate (P less than 0.05) at 45 min with an increased cardiac output (P less than 0.05) persisting above baseline values at 1 h, but with no change in stroke volume. 4. These results support a biphasic mode of action for ibopamine which may be explained by a time phase difference in alpha- and beta-adrenoceptor stimulatory effects.
No takes yet. Share an insight, caveat, or question.
Hogg et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: